173 related articles for article (PubMed ID: 11604021)
1. Toward an optimal procedure for variable selection and QSAR model building.
Yasri A; Hartsough D
J Chem Inf Comput Sci; 2001; 41(5):1218-27. PubMed ID: 11604021
[TBL] [Abstract][Full Text] [Related]
2. Evolutionary computation and QSAR research.
Aguiar-Pulido V; Gestal M; Cruz-Monteagudo M; Rabuñal JR; Dorado J; Munteanu CR
Curr Comput Aided Drug Des; 2013 Jun; 9(2):206-25. PubMed ID: 23700999
[TBL] [Abstract][Full Text] [Related]
3. Neural networks in building QSAR models.
Baskin II; Palyulin VA; Zefirov NS
Methods Mol Biol; 2008; 458():137-58. PubMed ID: 19065809
[TBL] [Abstract][Full Text] [Related]
4. From Classification to Regression Multitasking QSAR Modeling Using a Novel Modular Neural Network: Simultaneous Prediction of Anticonvulsant Activity and Neurotoxicity of Succinimides.
Antanasijević D; Antanasijević J; Trišović N; Ušćumlić G; Pocajt V
Mol Pharm; 2017 Dec; 14(12):4476-4484. PubMed ID: 29130688
[TBL] [Abstract][Full Text] [Related]
5. QSAR modeling for quinoxaline derivatives using genetic algorithm and simulated annealing based feature selection.
Ghosh P; Bagchi MC
Curr Med Chem; 2009; 16(30):4032-48. PubMed ID: 19747124
[TBL] [Abstract][Full Text] [Related]
6. Variable selection methods in QSAR: an overview.
González MP; Terán C; Saíz-Urra L; Teijeira M
Curr Top Med Chem; 2008; 8(18):1606-27. PubMed ID: 19075770
[TBL] [Abstract][Full Text] [Related]
7. Application of GA-MLR for QSAR Modeling of the Arylthioindole Class of Tubulin Polymerization Inhibitors as Anticancer Agents.
Ahmadi S; Habibpour E
Anticancer Agents Med Chem; 2017; 17(4):552-565. PubMed ID: 27528182
[TBL] [Abstract][Full Text] [Related]
8. QSAR modeling of anti-invasive activity of organic compounds using structural descriptors.
Katritzky AR; Kuanar M; Dobchev DA; Vanhoecke BW; Karelson M; Parmar VS; Stevens CV; Bracke ME
Bioorg Med Chem; 2006 Oct; 14(20):6933-9. PubMed ID: 16908166
[TBL] [Abstract][Full Text] [Related]
9. Current approaches for choosing feature selection and learning algorithms in quantitative structure-activity relationships (QSAR).
Khan PM; Roy K
Expert Opin Drug Discov; 2018 Dec; 13(12):1075-1089. PubMed ID: 30372648
[TBL] [Abstract][Full Text] [Related]
10. Novel approach to evolutionary neural network based descriptor selection and QSAR model development.
Debeljak Z; Marohnić V; Srecnik G; Medić-Sarić M
J Comput Aided Mol Des; 2005 Dec; 19(12):835-55. PubMed ID: 16607572
[TBL] [Abstract][Full Text] [Related]
11. Partial least squares modeling and genetic algorithm optimization in quantitative structure-activity relationships.
Hasegawa K; Funatsu K
SAR QSAR Environ Res; 2000; 11(3-4):189-209. PubMed ID: 10969871
[TBL] [Abstract][Full Text] [Related]
12. A self-adaptive genetic algorithm-artificial neural network algorithm with leave-one-out cross validation for descriptor selection in QSAR study.
Wu J; Mei J; Wen S; Liao S; Chen J; Shen Y
J Comput Chem; 2010 Jul; 31(10):1956-68. PubMed ID: 20512843
[TBL] [Abstract][Full Text] [Related]
13. Evolutionary optimization in quantitative structure-activity relationship: an application of genetic neural networks.
So SS; Karplus M
J Med Chem; 1996 Mar; 39(7):1521-30. PubMed ID: 8691483
[TBL] [Abstract][Full Text] [Related]
14. Pre-processing feature selection for improved C&RT models for oral absorption.
Newby D; Freitas AA; Ghafourian T
J Chem Inf Model; 2013 Oct; 53(10):2730-42. PubMed ID: 24050619
[TBL] [Abstract][Full Text] [Related]
15. Predictive QSAR modeling of HIV reverse transcriptase inhibitor TIBO derivatives.
Mandal AS; Roy K
Eur J Med Chem; 2009 Apr; 44(4):1509-24. PubMed ID: 18760864
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the internal representations developed by neural networks for structures applied to quantitative structure--activity relationship studies of benzodiazepines.
Micheli A; Sperduti A; Starita A; Bianucci AM
J Chem Inf Comput Sci; 2001; 41(1):202-18. PubMed ID: 11206375
[TBL] [Abstract][Full Text] [Related]
17. Modeling the activity of furin inhibitors using artificial neural network.
Worachartcheewan A; Nantasenamat C; Naenna T; Isarankura-Na-Ayudhya C; Prachayasittikul V
Eur J Med Chem; 2009 Apr; 44(4):1664-73. PubMed ID: 18977558
[TBL] [Abstract][Full Text] [Related]
18. Toward an optimal procedure for PC-ANN model building: prediction of the carcinogenic activity of a large set of drugs.
Hemmateenejad B; Safarpour MA; Miri R; Nesari N
J Chem Inf Model; 2005; 45(1):190-9. PubMed ID: 15667145
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Multiple Linear Regressions and Neural Networks based QSAR models for the design of new antitubercular compounds.
Ventura C; Latino DA; Martins F
Eur J Med Chem; 2013; 70():831-45. PubMed ID: 24246731
[TBL] [Abstract][Full Text] [Related]
20. Feature selection methods in QSAR studies.
Goodarzi M; Dejaegher B; Vander Heyden Y
J AOAC Int; 2012; 95(3):636-51. PubMed ID: 22816254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
